Use of an Ocular Telemetry Sensor in Diamox Treated Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01028664
Recruitment Status : Completed
First Posted : December 9, 2009
Last Update Posted : December 3, 2010
Clinique de Montchoisi, Lausanne, Switzerland
Information provided by:
Sensimed AG

December 7, 2009
December 9, 2009
December 3, 2010
December 2009
October 2010   (Final data collection date for primary outcome measure)
Detection of IOP reduction 2 hours after Diamox administration [ Time Frame: 2 hours ]
Same as current
Complete list of historical versions of study NCT01028664 on Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
Use of an Ocular Telemetry Sensor in Diamox Treated Patients
Detection of IOP Fluctuation With SENSIMED Triggerfish in Patients With Glaucoma or Ocular Hypertension Treated With Diamox
A soft contact lens integrating a Sensor is placed on subjects with high intraocular pressure (IOP) after administration of an IOP-lowering drug to investigate the device's capacity to detect the induced IOP reduction.
Not Provided
Not Applicable
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
  • Glaucoma
  • Ocular Hypertension
Device: SENSIMED Triggerfish
2-hour continuous IOP monitoring
Experimental: Glaucoma or ocular hypertension patients
Intervention: Device: SENSIMED Triggerfish
Not Provided

*   Includes publications given by the data provider as well as publications identified by Identifier (NCT Number) in Medline.
Same as current
October 2010
October 2010   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Confirmed diagnosis of glaucoma or ocular hypertension
  • IOP of ≥ 15 mmHg.
  • Patients of either gender.
  • Older than 18 years.
  • Patients who accept signing an informed consent approved by the Ethics Committee.

Exclusion Criteria:

  • Patients not able to understand the nature of the research
  • Patients under tutorship
  • Corneal abnormalities in both eyes
  • Subjects with contraindications for wearing contact lenses
  • History of ocular surgery within the last 3 months
  • Known hypersensitivity to Diamox® or to any of its excipients
  • Pregnancy and lactation
  • Simultaneous participation in other clinical research
  • Patients with evidence of ocular infection or inflammation
  • History of renal or hepatic impairment, hypokalemia and hyponatremia
Sexes Eligible for Study: All
18 Years to 80 Years   (Adult, Senior)
Contact information is only displayed when the study is recruiting subjects
Not Provided
Not Provided
Prof. André Mermoud, Clinique de Montchoisi
Sensimed AG
Clinique de Montchoisi, Lausanne, Switzerland
Not Provided
Sensimed AG
December 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP